Development Level

Tchem 2 | 1,890
Tclin 2 | 602
Tbio 1 | 10,625

Disease

lung cancer 5 | 4,466
Animal Mammary Neoplasms 4 | 136
Breast cancer 4 | 3,094
Mammary Neoplasms 4 | 410
Mammary Neoplasms, Experimental 4 | 150
Prostatic Neoplasms 4 | 471
psoriasis 4 | 6,685
Cancer 3 | 2,346
Neoplastic Cell Transformation 3 | 81
Vascular disease 3 | 281
astrocytoma 3 | 1,493
ductal carcinoma in situ 3 | 1,745
malignant mesothelioma 3 | 3,162
osteosarcoma 3 | 7,933
ovarian cancer 3 | 8,484
Adenocarcinoma 2 | 115
Adenoid Cystic Carcinoma 2 | 99
Adenoma 2 | 165
Alzheimer's disease 2 | 644
Atrophic vaginitis 2 | 14
Bladder Neoplasm 2 | 109
Breast Cancer, Familial 2 | 12
Breast disease 2 | 8
Carcinoma 2 | 2,147
Carcinoma, Transitional Cell 2 | 31
Colorectal Neoplasms 2 | 217
Coronary artery disease 2 | 240
Dyspareunia 2 | 3
Endometrial Neoplasms 2 | 50
Endometriosis 2 | 535
Female hypogonadism syndrome 2 | 7
Female infertility 2 | 28
Infertility 2 | 163
Leukemia 2 | 88
Liver carcinoma 2 | 217
Lobular neoplasia 2 | 15
Lung Neoplasms 2 | 171
Male infertility 2 | 170
Menopausal flushing 2 | 17
Metastatic Breast Cancer Progression Post-Antiestrogen Therapy 2 | 4
Osteoporosis 2 | 257
Peripheral Neuropathy 2 | 303
Postmenopausal osteoporosis 2 | 19
Prevention of Breast Carcinoma 2 | 5
Prostate cancer 2 | 172
Prostatic Intraepithelial Neoplasias 2 | 11
colon cancer 2 | 1,475
cystic fibrosis 2 | 1,665
glioblastoma 2 | 5,572
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 2 | 3,289
medulloblastoma, large-cell 2 | 6,234
nasopharyngeal carcinoma 2 | 1,056
pituitary cancer 2 | 1,972
primitive neuroectodermal tumor 2 | 3,031
ATHEROSCLEROSIS, SUSCEPTIBILITY TO 1 | 3
Breast fibroadenoma 1 | 8
Carcinoma of female breast 1 | 20
Chronic Lymphocytic Leukemia 1 | 242
Colorectal Cancer 1 | 47
ESTROGEN RESISTANCE 1 | 1
Endometrial cancer 1 | 25
Esophageal Neoplasms 1 | 67
Familial adenomatous polyposis 1 | 31
Female Urogenital Diseases 1 | 18
Feminization 1 | 1
Fibroid Tumor 1 | 6
Glomerulonephritis 1 | 36
HDL CHOLESTEROL, AUGMENTED RESPONSE OF, TO HORMONE REPLACEMENT 1 | 1
Hyperparathyroidism 1 | 43
Idiopathic scoliosis 1 | 29
Kidney Neoplasm 1 | 27
Kidney cancer 1 | 118
Leiomyoma 1 | 25
Lynch syndrome 1 | 33
Malignant neoplasm of ovary 1 | 13
Metabolic Bone Disorder 1 | 11
Metastatic Breast Carcinoma 1 | 21
Metastatic Prostate Carcinoma 1 | 18
Migraine Disorders 1 | 26
Mouth Diseases 1 | 12
Myocardial Infarction 1 | 126
Neoplasm Metastasis 1 | 138
Neoplasm Recurrence, Local 1 | 23
Neoplastic Syndromes, Hereditary 1 | 48
Nijmegen breakage syndrome 1 | 23
Oligospermia 1 | 30
Ovarian dysfunction 1 | 19
Pancreatic carcinoma, familial 1 | 8
Papilloma 1 | 27
Precancerous Conditions 1 | 69
Primary hyperparathyroidism 1 | 4
Psychoses, Substance-Induced 1 | 17
Retinoblastoma 1 | 14
Salivary Gland Neoplasms 1 | 45
Squamous cell carcinoma of esophagus 1 | 82
Sudden Cardiac Arrest 1 | 16
Thyroid Neoplasm 1 | 33
Uterine fibroid 1 | 29
ovarian neoplasm 1 | 97

Tissue

Blood and immune system 5 | 17,995
Cardiovascular System 5 | 17,958
Digestive Tract 5 | 18,473
Endocrine System 5 | 18,512
Female tissues 5 | 18,647
Liver and Pancreas 5 | 18,136
Male tissues 5 | 17,969
Nervous System 5 | 18,561
Respiratory system 5 | 17,484
Skin and soft tissues 5 | 18,115
Urinary Tract 5 | 18,444

Target Family

Non-IDG 2 | 11,971
Nuclear Receptor 2 | 48
Enzyme 1 | 4,146

Grant Application

3U54CA100970-05S1 5 | 5
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
G1/S-specific cyclin-D1 CCND1 Tchem Non-IDG -3.77851 5447.1 1111
Estrogen receptor ESR1 Tclin Nuclear Receptor -3.97123 8119.2 2214
Breast cancer type 1 susceptibility protein BRCA1 Tchem Non-IDG -3.72596 5756.8 1322
Estrogen receptor beta ESR2 Tclin Nuclear Receptor -3.53167 3575.4 950
GTPase Era, mitochondrial ERAL1 Tbio Enzyme -2.18799 179.3 119